[1]
Lui, D. et al. 2022. EVALUATION OF FRACTURE RISK AMONG TYPE 2 DIABETES PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION RECEIVING DIFFERENT ORAL ANTICOAGULANTS. Journal of the ASEAN Federation of Endocrine Societies. 37, 2 (Oct. 2022), 30. DOI:https://doi.org/10.15605/jafes.037.AFES.40.